NIBEC Co. Ltd (138610) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.024x

Based on the latest financial reports, NIBEC Co. Ltd (138610) has a cash flow conversion efficiency ratio of 0.024x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.13 Billion ≈ $765.98K USD) by net assets (₩47.02 Billion ≈ $31.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is NIBEC Co. Ltd's balance sheet to measure how much of total assets are equity-financed.

NIBEC Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how NIBEC Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of NIBEC Co. Ltd to evaluate the quality of earnings relative to operating cash generation.

NIBEC Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NIBEC Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Schloss Wachenheim AG
F:SWA
-0.008x
Wanbury Limited
NSE:WANBURY
-0.053x
Pha Lai Thermal Power JSC
VN:PPC
-0.075x
Grupo Sports World S.A.B. de C.V
MX:SPORTS
0.129x
Ferronordic AB (publ)
ST:FNM
-0.108x
Comscore Inc
NASDAQ:SCOR
0.016x
Hanmiglobal
KO:053690
-0.005x
Lumi Gruppen AS
OL:LUMI
0.171x

Annual Cash Flow Conversion Efficiency for NIBEC Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of NIBEC Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see how much is NIBEC Co. Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩45.82 Billion
≈ $31.05 Million
₩5.82 Billion
≈ $3.94 Million
0.127x +1305.36%
2024-12-31 ₩32.23 Billion
≈ $21.84 Million
₩291.25 Million
≈ $197.38K
0.009x +113.30%
2023-12-31 ₩28.84 Billion
≈ $19.55 Million
₩-1.96 Billion
≈ $-1.33 Million
-0.068x -145.98%
2022-12-31 ₩36.80 Billion
≈ $24.94 Million
₩5.44 Billion
≈ $3.69 Million
0.148x +394.14%
2021-12-31 ₩27.34 Billion
≈ $18.53 Million
₩817.97 Million
≈ $554.33K
0.030x +289.86%
2020-12-31 ₩31.84 Billion
≈ $21.58 Million
₩-501.66 Million
≈ $-339.97K
-0.016x +50.23%
2019-12-31 ₩27.40 Billion
≈ $18.57 Million
₩-867.62 Million
≈ $-587.97K
-0.032x +85.49%
2018-12-31 ₩10.58 Billion
≈ $7.17 Million
₩-2.31 Billion
≈ $-1.56 Million
-0.218x -578.82%
2017-12-31 ₩12.36 Billion
≈ $8.38 Million
₩563.22 Million
≈ $381.68K
0.046x +220.46%
2016-12-31 ₩9.84 Billion
≈ $6.67 Million
₩-372.21 Million
≈ $-252.24K
-0.038x +80.82%
2015-12-31 ₩10.82 Billion
≈ $7.33 Million
₩-2.13 Billion
≈ $-1.45 Million
-0.197x -10.83%
2014-12-31 ₩5.08 Billion
≈ $3.44 Million
₩-903.85 Million
≈ $-612.53K
-0.178x --

About NIBEC Co. Ltd

KQ:138610 Korea Biotechnology
Market Cap
$107.93 Million
₩159.26 Billion KRW
Market Cap Rank
#18857 Global
#861 in Korea
Share Price
₩14010.00
Change (1 day)
+2.19%
52-Week Range
₩12200.00 - ₩52300.00
All Time High
₩55200.00
About

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is base… Read more